Evidence map›Paper›PMID 33240781›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Label-Free Imaging of Cholesterol Assemblies Reveals Hidden Nanomechanics of Breast Cancer Cells.

Andra C Dumitru, Danahe Mohammed, Mauriane Maja, Jinsung Yang, Sandrine Verstraeten, Aranzazu Del Campo, Marie-Paule Mingeot-Leclercq, Donatienne Tyteca, David Alsteens

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andra C DumitruLouvain Institute of Biomolecular Science and Technology (LIBST) Université catholique de Louvain Louvain-la-Neuve 1348 Belgium.
Danahe MohammedLouvain Institute of Biomolecular Science and Technology (LIBST) Université catholique de Louvain Louvain-la-Neuve 1348 Belgium.
Mauriane MajaCell Biology (CELL) Unit de Duve Institute Université catholique de Louvain Brussels 1200 Belgium.
Jinsung YangLouvain Institute of Biomolecular Science and Technology (LIBST) Université catholique de Louvain Louvain-la-Neuve 1348 Belgium.
Sandrine VerstraetenCellular and Molecular Pharmacology Unit (FACM) Louvain Drug Research Institute Université catholique de Louvain Brussels 1200 Belgium.
Aranzazu Del CampoINM - Leibniz-Institut für Neue Materialien gGmbH Campus D2 2 Saarbrücken 66123 Germany.ORCID https://orcid.org/0000-0001-5725-2135
Marie-Paule Mingeot-LeclercqCellular and Molecular Pharmacology Unit (FACM) Louvain Drug Research Institute Université catholique de Louvain Brussels 1200 Belgium.
Donatienne TytecaCell Biology (CELL) Unit de Duve Institute Université catholique de Louvain Brussels 1200 Belgium.
David AlsteensLouvain Institute of Biomolecular Science and Technology (LIBST) Université catholique de Louvain Louvain-la-Neuve 1348 Belgium.ORCID https://orcid.org/0000-0001-9229-113X
UCLouvain · BEde Duve Institute · BELeibniz-Institute for New Materials · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor cells present profound alterations in their composition, structural organization, and functional properties. A landmark of cancer cells is an overall altered mechanical phenotype, which so far are linked to changes in their cytoskeletal regulation and organization. Evidence exists that the plasma membrane (PM) of cancer cells also shows drastic changes in its composition and organization. However, biomechanical characterization of PM remains limited mainly due to the difficulties encountered to investigate it in a quantitative and label-free manner. Here, the biomechanical properties of PM of a series of MCF10 cell lines, used as a model of breast cancer progression, are investigated. Notably, a strong correlation between the cell PM elasticity and oncogenesis is observed. The altered membrane composition under cancer progression, as emphasized by the PM-associated cholesterol levels, leads to a stiffening of the PM that is uncoupled from the elastic cytoskeletal properties. Conversely, cholesterol depletion of metastatic cells leads to a softening of their PM, restoring biomechanical properties similar to benign cells. As novel therapies based on targeting membrane lipids in cancer cells represent a promising approach in the field of anticancer drug development, this method contributes to deciphering the functional link between PM lipid content and disease.

Indexed as

atomic force microscopycancer cellscell mechanicscholesterolplasma membrane

Identifiers

PMID33240781
PMCPMC7675049
OpenAlexW3092189793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.